ALB

Albemarle Corp. 10-Q Summary: Period Ended September 30, 2001

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended September 30, 2001, and the nine-month period ended on that date. Albemarle Corporation is a global manufacturer of specialty polymer and fine chemicals, organized into two operating segments: Polymer Chemicals and Fine Chemicals. The reporting period includes the impact of two significant acquisitions: Martinswerk GmbH (completed May 31, 2001) and the custom and fine chemicals businesses of ChemFirst Inc. (completed July 1, 2001).

Key Financial Metrics

Note: Debt figures reflect a significant increase in current portion of long-term debt due to the Revolving Credit Agreement maturing in 2002.

Material Changes vs. Prior Period

• Revenue: Q3 sales increased 2.1% year-over-year, driven by $45.8M in sales from new acquisitions, offset by lower shipments and pricing in flame retardants, catalysts, and zeolites. Nine-month sales declined 3.0% due to similar headwinds and foreign exchange impacts.
• Profitability: Operating profit declined 27.3% in Q3 and 39.0% for the nine months. The nine-month decline is partially attributed to a one-time noncash pension settlement gain of $15.9M recorded in 2000 (SFAS No. 88) which did not recur in 2001. Excluding this gain, the nine-month operating profit decline was 30.2%.
• Margins: Gross profit margins compressed significantly, dropping from 29.0% to 23.4% in Q3 and from 30.0% to 24.3% for the nine months, due to lower utilization, raw material costs, and pricing pressure.
• Debt Structure: Total debt increased from $98.0M at year-end 2000 to $184.0M at September 30, 2001. This increase was primarily to finance the acquisitions of Martinswerk and ChemFirst. The majority of this debt ($171.6M) is classified as current due to the upcoming maturity of the Revolving Credit Agreement.

Guidance, Outlook, and Risks

• Outlook: Management expects "more of the same" for Polymer Chemicals in the near term, with potential price pressure in flame retardants due to the electronics market slowdown, though a volume rebound is hoped for by mid-2002. Catalysts and additives markets are expected to remain flat. Fine Chemicals outlook is positive, with momentum expected to continue in agrichemicals and pharmachemicals.
• Capital Expenditures: Forecasted to be higher than 2000 levels for the full year, financed primarily by operating cash flow and debt.
• Risks: Key risks include the timing of customer orders, competition, raw material costs, foreign currency fluctuations, and the need to manage inventory levels. The company faces environmental liabilities (e.g., Superfund) but does not expect them to have a material adverse effect.
• Unusual Items: The 2000 period included a $15.9M noncash pension settlement gain. The 2001 period includes pro-forma adjustments for acquisitions and a reversal of a deferred tax valuation allowance in Belgium.

Investor Verification Checklist

• Debt Maturity: Verify the status of refinancing the $171.6M Revolving Credit Agreement maturing September 29, 2002, which is currently classified as a current liability.
• Acquisition Integration: Assess the performance of the newly acquired Martinswerk and ChemFirst businesses against pro-forma expectations.
• Margin Recovery: Monitor gross margin trends in the flame retardant and zeolite segments to determine if pricing pressures are stabilizing.
• Capital Allocation: Review the balance between capital expenditures for new projects and debt repayment obligations.
• Foreign Exchange: Evaluate the impact of the strengthening U.S. Dollar on European and Asia Pacific operations.